Copyright
©The Author(s) 2023.
World J Stem Cells. Jun 26, 2023; 15(6): 632-653
Published online Jun 26, 2023. doi: 10.4252/wjsc.v15.i6.632
Published online Jun 26, 2023. doi: 10.4252/wjsc.v15.i6.632
Ref. | Application | Characterization | Evaluation technique | Outcomes |
Kurosawa et al[18] | Build and evaluate a BBB 3D in vitro model | Capillary structure formation and tight junction proteins expression | Immunocytochemistry | Formation of the capillary structure, functional tight proteins; lower expression of ABC transporters than levels found in vivo, except for BCRP; expression of functional SLC transporters |
Transport proteins and receptors expression | Immunocytochemistry | |||
qPCR | ||||
Tight junction functionality | Fluorescence (lucifer yellow and antipyrine) | |||
HPLC-MS/MS (test-drug transport) | ||||
Transport proteins function | HPLC-MS/MS (test-drug transport) | |||
Fengler et al[19] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Capillary diameter CA. 40 times larger than in vivo brain vessels; physiologically relevant TEER values; physiologically similar localization of BCRP and GLUT-1 proteins. Promising BBB model for future drug screening tests |
Microvessel integrity | Fluorescence (DEX-A647 and sodium fluorescein) | |||
Microvessel permeability | Diazepam, Emricasan, Ac-YVAD-CMK, Z-DEVD-FMK, ZVAD (OH)-FMK, Staurosporine, and IL-1β | |||
Tight junction functionality | ELISA (Diazepam) | |||
TEER measurements | ||||
Wevers et al[20] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Barrier functionality similar to that found in vivo; microfluidic model suitable for evaluating disruption of the BBB; successful ischemic stroke modeling. Potential use for modeling the BBB under sub-optimal conditions (disease) and for evaluating potential therapies |
Tight junction functionality | TEER measurements | |||
Microvessel permeability | Fluorescence (sodium fluorescein) | |||
Transport proteins expression | Fluorescence: P-gp inhibition | |||
qPCR | ||||
Neuronal functionality | Calcium fluorescence imaging | |||
Ischemic stroke modeling | Microvessel permeability | Fluorescence (FITC-dextran) | ||
Mitochondrial membrane potential | Luminescence (CellTiter-GLO) | |||
ATP quantification | ||||
Noorani et al[21] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | BBB functionality remains intact for up to 7 d and is similar to that found in vivo; a more physiologically relevant BBB model; shear stress contributes positively to BBB tightness |
Microvessel permeability | UPLC-MS/MS: [13C12] sucrose and [13C6] mannitol | |||
Transport proteins expression | Immunocytochemistry | |||
Fluorescence: P-gp inhibition | ||||
Middelkamp et al[22] | Compare 2D cultures to microfluidic chip cultures | Neuronal differentiation and characterization of HUVECs | Immunocytochemistry | Culture in microfluidic chips promotes gene expression that more closely resembles that found in vivo |
RNA sequencing | ||||
Transcriptomic analysis | ||||
Choi et al[23] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | cECMTE membrane with 10 m pores in microfluidic device were successful in mimicking the in vivo BBB, also allowing for cancer cell tissue migration. Promising BBB model for studying cancer metastasis, cell communication, and migration |
qPCR | ||||
Tight junction functionality | Fluorescence (lucifer yellow) | |||
Transendothelial migration of cancer cells (CellMask) | ||||
Immunocytochemistry | ||||
Transport proteins expression | Immunocytochemistry | |||
Motallebnejad et al[24] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | LM511-E8 ECM contributes to long-lasting endothelial cell and BBB function, in addition to promoting better shear stress responses. Authors recommend the use of LM511-E8 ECM for future studies involving BBB function |
Fluorescence (F-actin staining) | ||||
qPCR | ||||
Tight junction functionality | TEER measurements | |||
Fluorescence (rhodamine B-labeled neutral dextran) | ||||
Lee et al[25] | BBB permeability to polymer nanoparticles | Tight junction and transport proteins expression | qPCR | Fast analysis of polymer nanoparticles permeability; physiologically reliable BBB model |
Permeability to polymer nanoparticles | Fluorescence (polymer nanoparticles and FITC-dextran) | |||
3D fluorescence intensity maps | ||||
Jagadeesan et al[26] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Successful fabrication of BBB model personalized for different human individuals; BBB models were able to mimic physiological differences between healthy and ill individuals |
Tight junction functionality and microvessel permeability | Fluorescence: FITC-dextran | |||
Transport proteins expression | Immunocytochemistry | |||
Neuronal differentiation | ||||
Vatine et al[27] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Successful fabrication of BBB model personalized for different human individuals; BBB models were able to mimic physiological differences between healthy and ill individuals |
Transcriptional analysis | ||||
Microvessel permeability and tight junction functionality | Fluorescence (FITC-dextran and 2NDBG) | |||
ELISA (human albumin, IgG and transferrin) | ||||
LC-MS/MS (T3, colchicine, levetiracetam and retigabine) | ||||
Transmission light microscopy | ||||
TEER measurements | ||||
Immunocytochemistry | ||||
Transport proteins expression | Immunocytochemistry | |||
Transcriptional analysis | ||||
Transport protein function | Fluorescence (rhodamine-123) | |||
Whole-blood neuronal toxicity | Colorimetric assay (quantification of lactic dehydrogenase) | |||
Neuronal functionality | Immunocytochemistry | |||
Calcium fluorescence imaging | ||||
Park et al[28] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | BBB functionality remains intact for up to 7 d. Promising BBB model for future drug and antibody transport studies |
Multiplex qPCR | ||||
MS (proteomics) | ||||
Tight junction functionality and microvessel permeability | Electron transmission microscopy | |||
TEER measurements | ||||
Fluorescence (dextrans, cetuximab, angiopep-2, MEM75, 13E4) | ||||
ELISA (dextrans, cetuximab) | ||||
Transport proteins expression | Immunocytochemistry | |||
MS | ||||
Transport proteins function | Fluorescence (rhodamine-123 and doxorubicin) | |||
Campisi et al[29] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Tri-culture of human iPSC-derived endothelial cells, astrocytes and pericytes spontaneously arranged into a BBB-like model. Promising BBB model for future preclinical experiments |
qPCR | ||||
Tight junction functionality and microvessel permeability | Fluorescence (FITC-dextran) | |||
Characterization of astrocytes and pericytes | Immunocytochemistry | |||
Wang et al[30] | Build and evaluate a BBB 3D in vitro model | Tight junction proteins expression | Immunocytochemistry | Pumpless media perfusion system that resembles the blood residence time within brain tissues; physiologically relevant TEER values maintained for up to 10 d. Promising BBB model for future drug permeability studies |
Tight junction functionality and microvessel permeability | TEER measurements | |||
Fluorescence: FITC-dextran and doxorubicin | ||||
LC-MS/MS (caffeine and cimetidine) | ||||
DeStefano et al[31] | Evaluate BBB upon shear stress | Characterization of iPSC-derived endothelial cells morphology and function | Microscopy (time-lapse imaging analysis using ImageJ) | BBB endothelial cells display unique features that differ from endothelial cells from other tissues; shear stress plays a key role in BBB-like function in microfluidic models |
Tight junction proteins expression | Immunocytochemistry | |||
Western blot | ||||
qPCR | ||||
Transport proteins expression | qPCR |
- Citation: Alves ADH, Nucci MP, Ennes do Valle NM, Missina JM, Mamani JB, Rego GNA, Dias OFM, Garrigós MM, de Oliveira FA, Gamarra LF. Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip. World J Stem Cells 2023; 15(6): 632-653
- URL: https://www.wjgnet.com/1948-0210/full/v15/i6/632.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i6.632